Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 24;6(11):4666-82.
doi: 10.3390/v6114666.

Euthanasia assessment in ebola virus infected nonhuman primates

Affiliations

Euthanasia assessment in ebola virus infected nonhuman primates

Travis K Warren et al. Viruses. .

Abstract

Multiple products are being developed for use against filoviral infections. Efficacy for these products will likely be demonstrated in nonhuman primate models of filoviral disease to satisfy licensure requirements under the Animal Rule, or to supplement human data. Typically, the endpoint for efficacy assessment will be survival following challenge; however, there exists no standardized approach for assessing the health or euthanasia criteria for filovirus-exposed nonhuman primates. Consideration of objective criteria is important to (a) ensure test subjects are euthanized without unnecessary distress; (b) enhance the likelihood that animals exhibiting mild or moderate signs of disease are not prematurely euthanized; (c) minimize the occurrence of spontaneous deaths and loss of end-stage samples; (d) enhance the reproducibility of experiments between different researchers; and (e) provide a defensible rationale for euthanasia decisions that withstands regulatory scrutiny. Historic records were compiled for 58 surviving and non-surviving monkeys exposed to Ebola virus at the US Army Medical Research Institute of Infectious Diseases. Clinical pathology parameters were statistically analyzed and those exhibiting predicative value for survival are reported. These findings may be useful for standardization of objective euthanasia assessments in rhesus monkeys exposed to Ebola virus and may serve as a useful approach for other standardization efforts.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Serum BUN responses in rhesus monkeys exposed to Ebola virus. Symbols represent the maximal serum BUN value obtained at any time during the course of infection for an individual animal (diamonds = survivors, circles = non-survivors). Data were compiled from multiple independent historic experiments. The horizontal gray line indicates a survival threshold, i.e., the maximal value obtained in any animal that survived infection. The red line indicates a proposed euthanasia threshold value based on ROC curve suggested values plus 10%. Black lines are the group mean. Normative serum BUN reference range for rhesus monkeys (mean +/− 1 SD) is 15–21 mg/dL [21].
Figure 2
Figure 2
Serum CRE responses in rhesus monkeys exposed to Ebola virus. Symbols represent the maximal serum CRE value obtained at any time during the course of infection for an individual animal (diamonds = survivors, circles = non-survivors). Data were compiled from multiple independent historic experiments. The horizontal gray line indicates a survival threshold, i.e., the maximal value obtained in any animal that survived infection. The red line indicates a proposed euthanasia threshold value based on ROC curve suggested values plus 10%. Black lines are the group mean. Normative serum CRE reference range for rhesus monkeys (mean +/− 1 SD) is 0.45–0.71 mg/dL [21].
Figure 3
Figure 3
Serum GGT responses in rhesus monkeys exposed to Ebola virus. Symbols represent the maximal serum GGT value obtained at any time during the course of infection for an individual animal (diamonds = survivors, circles = non-survivors). Data were compiled from multiple independent historic experiments. The horizontal gray line indicates a survival threshold, i.e., the maximal value obtained in any animal that survived infection. The red line indicates a proposed euthanasia threshold value based on ROC curve suggested values plus 10%. Black lines are the group mean. Normative serum GGT reference range for rhesus monkeys (mean +/− 1 SD) is 66–97 U/L [21].
Figure 4
Figure 4
Serum total calcium responses in rhesus monkeys exposed to Ebola virus. Symbols represent the minimal serum total calcium value obtained at any time during the course of infection for an individual animal (diamonds = survivors, circles = non-survivors). Data were compiled from multiple independent historic experiments. The horizontal gray line indicates a survival threshold, i.e., the maximal value obtained in any animal that survived infection. The red line indicates a proposed euthanasia threshold value based on ROC curve suggested values plus 10%. Black lines are the group mean. Normative serum total calcium reference range for rhesus monkeys (mean +/− 1 SD) is 8.6–9.2 mg/dL [21].
Figure 5
Figure 5
Flow diagram depicting a proposed euthanasia decision tree for Ebola virus infected rhesus monkeys.

References

    1. Dye J.M., Herbert A.S., Kuehne A.I., Barth J.F., Muhammad M.A., Zak S.E., Ortiz R.A., Prugar L.I., Pratt W.D. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc. Natl. Acad. Sci. USA. 2012;109:5034–5039. doi: 10.1073/pnas.1200409109. - DOI - PMC - PubMed
    1. Geisbert T.W., Hensley L.E., Geisbert J.B., Leung A., Johnson J.C., Grolla A., Feldmann H. Postexposure treatment of Marburg virus infection. Emerg. Infect. Dis. 2010;16:1119–1122. doi: 10.3201/eid1607.100159. - DOI - PMC - PubMed
    1. Geisbert T.W., Lee A.C., Robbins M., Geisbert J.B., Honko A.N., Sood V., Johnson J.C., de Jong S., Tavakoli I., Judge A., et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: A proof-of-concept study. Lancet. 2010;375:1896–1905. doi: 10.1016/S0140-6736(10)60357-1. - DOI - PMC - PubMed
    1. Sullivan N.J., Geisbert T.W., Geisbert J.B., Xu L., Yang Z.Y., Roederer M., Koup R.A., Jahrling P.B., Nabel G.J. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature. 2003;424:681–684. doi: 10.1038/nature01876. - DOI - PMC - PubMed
    1. Warren T.K., Warfield K.L., Wells J., Swenson D.L., Donner K.S., Van Tongeren S.A., Garza N.L., Dong L., Mourich D.V., Crumley S., et al. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat. Med. 2010;16:991–994. doi: 10.1038/nm.2202. - DOI - PubMed

Publication types

LinkOut - more resources